# Samsung Medical Center: Observational study in Gastric Cancer, Colorectal Cancer (118750 participants)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | Samsung Medical Center |
| Sponsor type | Academic and hospital |
| Study | Development and Utilization of an Integrated Clinical Genomic Database |
| NCT ID | NCT07911267 |
| Phase | Observational |
| Status | recruiting |
| Conditions | Gastric Cancer; Colorectal Cancer; Lung Cancer (NSCLC); Liver Cancer; Pancreatic Cancer |
| Target enrollment | 118750 |
| Site countries | South Korea |
| Posted | 2026-11-02 |
| Planned start | 2024-12-06 |
| Event | Newly registered study |
| Event date | 2026-11-02 |

## Why this score
- Posted in the last two weeks.
- 118750 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07911267). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.